113 results on '"Hirsch, Irl B"'
Search Results
2. Malglycemia in the critical care setting. Part II: Relative and absolute hypoglycemia
3. Differential Association between Blood Glucose Levels and Nonrelapse Mortality after Allogeneic Hematopoietic Cell Transplantation Based on Presence or Absence of Preexisting Diabetes
4. Malglycemia in the critical care setting. Part I: Defining hyperglycemia in the critical care setting using the glycemic ratio
5. American Association of Clinical Endocrinology Consensus Statement: Comprehensive Type 2 Diabetes Management Algorithm – 2023 Update
6. ABCC8-Related Monogenic Diabetes Presenting Like Type 1 Diabetes in an Adolescent
7. The DERMIS Study: Evaluation of Insulin Pump Infusion Sites in Type 1 Diabetes
8. Malglycemia in the Critical Care Setting. Part I: Defining Hyperglycemia in the Critical Care Setting Using the Glycemic Ratio
9. Continuous glucose monitoring and metrics for clinical trials: an international consensus statement
10. Baseline risk markers and visit-to-visit variability in relation to kidney outcomes – A post-hoc analysis of the PERL study
11. Insulin pricing in the USA: the saga continues
12. American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan—2022 Update
13. How introduction of automated insulin delivery systems may influence psychosocial outcomes in adults with type 1 diabetes: Findings from the first investigation with the Omnipod® 5 System
14. Blood glucose targets in the critically ill: is one size fits all still appropriate?
15. Prevalence of SGLT2i and GLP1RA use among US adults with type 2 diabetes
16. Effect of liraglutide on markers of insulin production in persons with type 2 diabetes treated with multiple daily insulin injections
17. Comparing Clinical Outcomes Between Two Continuous Glucose Monitors: Similar Diabetes-Related Events, All-Cause Hospitalizations and HbA1c Reductions in Type 1 and Type 2 Diabetes
18. Glycaemic management in diabetes: old and new approaches
19. Diabetes and the WHO Model List of Essential Medicines
20. Insulin Access and Cost at 100 Years: What Would Dr. Banting Think?
21. Variables associated with insulin production in persons with type 2 diabetes treated with multiple daily insulin injections
22. Temporal Relationship of Glycemia With Cardiac Arrhythmias in Patients With Type 2 Diabetes and CKD
23. Time to Follow the Evidence: Glycemic Control and Cardiovascular Benefits of New Diabetes Medications
24. A new look at brittle diabetes
25. Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2020 Executive Summary
26. HbA1c and Glucose Management Indicator Discordance: A Real-World Analysis
27. Bringing closure: towards achieving a better understanding of Israel
28. Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2019 Executive Summary
29. Clinically significant cognitive impairment in older adults with type 1 diabetes
30. ONE-YEAR TIME ANALYSIS IN AN ACADEMIC DIABETES CLINIC: QUANTIFYING OUR BURDEN
31. Intensive Diabetes Treatment and Cardiovascular Outcomes in Type 1 Diabetes Mellitus
32. Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2018 Executive Summary
33. Aace/ace Position Statement on the use of follow-on Biologics and Biosimilars for Endocrine Diseases
34. Professional Flash Continuous Glucose Monitoring with Ambulatory Glucose Profile Reporting to Supplement A1c: Rationale and Practical Implementation
35. Serum cystatin C in youth with diabetes: The SEARCH for diabetes in youth study
36. Incorporating Site-less Clinical Trials Into Drug Development: A Framework for Action
37. Safety and Efficacy of Personalized Glycemic Control in Critically ill Patients: A 2-Year Before and After Interventional Trial
38. Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive type 2 Diabetes Management Algorithm – 2017 Executive Summary
39. Progression To Insulin Dependence Post-Treatment With Immune Checkpoint Inhibitors In Pre-Existing Type 2 Diabetes
40. Takotsubo Cardiomyopathy In Association With Dka In A Blind Pump Patient
41. New Insulin Delivery Recommendations
42. Decisional practices and patterns of intraoperative glucose management in an academic medical center
43. Continuous Glucose Monitoring: A Consensus Conference of the American Association of Clinical Endocrinologists and American College of Endocrinology
44. American Association Of Clinical Endocrinologists And American College Of Endocrinology 2016 Outpatient Glucose Monitoring Consensus Statement
45. Consensus Statement By The American Association Of Clinical Endocrinologists And American College Of Endocrinology On The Comprehensive Type 2 Diabetes Management Algorithm – 2016 EXECUTIVE SUMMARY
46. Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm - 2015 Executive Summary
47. 1,5-Anhydroglucitol and Neonatal Complications in Pregnancy Complicated by Diabetes
48. American Association of Clinical Endocrinologists and American College of Endocrinology – Clinical Practice Guidelines for Developing A Diabetes Mellitus Comprehensive Care Plan – 2015 — Executive Summary
49. AACE/ACE Comprehensive Diabetes Management Algorithm 2015
50. American Association Of Clinical Endocrinologists And American College Of Endocrinology -Clinical Practice Guidelines For Developing A Diabetes Mellitus Comprehensive Care Plan – 2015
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.